J Allergy Clin Immunol Pract
Dr. Jeffrey G. Demain, MD
- Medicare services, 2024
- 97,911
- Medicare patients, 2024
- 230
- Part D claims, 2024
- 38
- Publications
- 19
- Hospital affiliations
- 1
- Practice address
- 3841 Piper St, Anchorage, AK 99508
- Practice phone
- Call (907) 562-6228
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Allergy Asthma and Immunology Center of Alaska
Anchorage, Alaska
Find Dr. Demain's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Jeffrey G. Demain is an allergist and immunologist in Anchorage, Alaska
Dr. Demain practices at Allergy Asthma and Immunology Center of Alaska in Anchorage, Alaska.
Dr. Demain's NPI, 1548201395, was assigned on June 10, 2006. Dr. Demain graduated from Texas Tech University Health Science Center School of Medicine in 1987. Dr. Demain holds Alaska license 3979.
- NPI
- 1548201395NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7810989399
- NPI enumeration date
- June 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Practice phone
- (907) 562-6228
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 65
- Medical school graduation
- 1987
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Jeffrey G. Demain practices at Allergy Asthma and Immunology Center of Alaska in Anchorage, Alaska
Dr. Demain's primary practice is Allergy Asthma and Immunology Center of Alaska, at 3841 Piper St, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 562-6228.
- Allergy Asthma and Immunology Center of Alaska3841 Piper St, Anchorage, AK 99508 · Anchorage BoroughPhone(907) 562-6228
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Jeffrey G. Demain is affiliated with 5 sites of care and 3 medical groups
Dr. Demain's primary practice is Allergy Asthma and Immunology Center of Alaska in Anchorage, Alaska. Dr. Demain is also affiliated with Providence Alaska Medical Center. The medical group on file is Allergy, Asthma and Immunology Center of Alaska. Dmand AI also links Dr. Demain to 3 more group practices and clinics and 2 medical groups, each named with a free account.
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Jeffrey G. Demain's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Demain practices, 4 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Allergy Asthma and Immunology Center of Alaska | Available with a free account |
| +4 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Jeffrey G. Demain is one of 9 allergists and immunologists in Alaska
Allergy and immunology is Dr. Demain's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dr. Demain is licensed in Alaska.
Specialties and state licenses
- Allergy and immunology, AlaskaPrimary
Allergists and immunologists near Dr. Demain
Counts of allergists and immunologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Jeffrey G. Demain billed Medicare for 97,911 services in 2024
CMS data shows 97,911 Medicare services from Dr. Demain across 9 procedure codes in 2024, for 230 Medicare patients. Medicare paid $849,417 for them. Every service was in an office.
Dr. Demain's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 2,1002024: 97,1544526%
- Tests and treatments
- 2023: 6022024: 73522%
- Office and hospital visits
- 2023: 902024: 2276%
Dr. Demain's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Demain?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Demain and other allergists and immunologists in Alaska.
Source: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data
Dr. Jeffrey G. Demain treated 230 Medicare patients in 2024, average age 71
CMS counts 230 Medicare patients who saw Dr. Demain in 2024. The largest group is 65 to 74, with 128 patients. 71% of them have high blood pressure, and 70% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.23, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Demain's median patient age at 59, with 65% women.
Dr. Demain's Medicare patients by age, 2024
Dr. Demain's Medicare patients by sex, 2024
- Women16270%
- Men6830%
Chronic conditions among Dr. Demain's Medicare patients, 2024
- High blood pressure71%
- High cholesterol70%
- Arthritis54%
- Ischemic heart disease34%
- Osteoporosis34%
- COPD24%
- Diabetes24%
- Anxiety23%
Share of Medicare patients with each condition. A patient can have several.
Dr. Demain's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 59
Patient panel by sex, all payers
- Women65%
- Men33%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Jeffrey G. Demain wrote 38 Medicare Part D claims in 2024
In 2024, Dr. Demain wrote 38 Medicare Part D claims for 18 patients. 74% of them were for generic drugs. They cover 9 drugs, with $66,479 in total drug cost. In 2022, CMS named 230 claims across 11 drugs.
Dr. Demain's Part D claims by kind of drug, 2024
- Generic28 claims74%
- Brand-name and other10 claims26%
Dr. Demain's most prescribed drugs by claims, 2023
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2022 to 2023
- 2022
- 2023
- Claims for drugs CMS names
- 2022: 2302023: 13840%
Drugs named by CMS: 9 in 2023, 11 in 2022.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
How Dr. Jeffrey G. Demain takes part in Medicare
Dr. Demain accepts Medicare assignment, so Medicare's approved amount is taken as full payment.
- Accepts Medicare assignment
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Jeffrey G. Demain has 19 publications on record
Dmand AI links 19 papers to Dr. Demain, published from 2011 to 2025. 2013 was the busiest year, with 3. The most frequent topics are Anaphylaxis, Insect Bites and Stings and Arthropod Venoms. Dr. Demain has published most often in J Allergy Clin Immunol Pract. Dr. Demain's most frequent co-authors are John R. Cohn, MD, David Alan Khan, MD and Wanda Phipatanakul, MD, MS.
Dr. Demain's papers by year, 2011 to 2025
Topics Dr. Demain writes about most
- Anaphylaxis
- Insect Bites and Stings
- Arthropod Venoms
- Hypersensitivity
- Desensitization, Immunologic
- Hymenoptera
- Insecta
- Skin Tests
Dr. Demain's most frequent co-authors
- John R. Cohn, MD3 shared papers
- David Alan Khan, MD2 shared papers
- Wanda Phipatanakul, MD, MS2 shared papers
Recent publications by Dr. Demain
J Allergy Clin Immunol Pract
J Allergy Clin Immunol Pract
J Allergy Clin Immunol Pract
See who Dr. Demain researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Demain works with, so you can find a warm path to the right allergists and immunologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Jeffrey G. Demain received $230,347 in industry payments from 2016 to 2025
CMS Open Payments shows 444 general payments to Dr. Demain from 36 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 64% of the total. Blueprint Medicines Corporation paid the most, $177,122.
General payments to Dr. Demain by program year, 2016 to 2025
General payments to Dr. Demain by kind, 2016 to 2025
- Honoraria$148,35364%
- Speaker and faculty fees$34,54215%
- Travel and lodging$31,27514%
- Food and beverage$12,7286%
- Other$3,4501%
Companies that paid Dr. Demain the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Jeffrey G. Demain graduated from Texas Tech University Health Science Center School of Medicine
Dr. Demain graduated from Texas Tech University Health Science Center School of Medicine in 1987.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Jeffrey G. Demain's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Jeffrey G. Demain
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Jeffrey G. Demain's NPI number?
Dr. Jeffrey G. Demain's NPI number is 1548201395. It was assigned on June 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Jeffrey G. Demain?
Dr. Jeffrey G. Demain is an allergist and immunologist in Anchorage, Alaska. The primary specialty in the NPI Registry is Allergy & Immunology Physician (taxonomy code 207K00000X).
Where does Dr. Jeffrey G. Demain practice?
Dr. Demain practices at 3841 Piper St, Anchorage, AK 99508. Dr. Demain's primary practice is Allergy Asthma and Immunology Center of Alaska in Anchorage, Alaska. Dmand AI also links Dr. Demain to 3 group practices and clinics and 2 medical groups.
What is Dr. Jeffrey G. Demain's office phone number?
The practice phone on file for Dr. Demain is (907) 562-6228.
What is Dr. Jeffrey G. Demain's medical license number?
Dr. Demain holds Alaska license 3979.
Which hospitals is Dr. Jeffrey G. Demain affiliated with?
Dr. Demain is affiliated with Providence Alaska Medical Center.
What medical group is Dr. Jeffrey G. Demain part of?
Dr. Demain is linked to Allergy, Asthma and Immunology Center of Alaska. Dmand AI links Dr. Demain to 2 more medical groups.
Does Dr. Jeffrey G. Demain accept Medicare?
Yes. CMS data shows Dr. Demain billed Medicare for 97,911 services in 2024, and Dr. Demain accepts Medicare assignment.
How many Medicare patients does Dr. Jeffrey G. Demain see?
CMS counts 230 Medicare patients who saw Dr. Demain in 2024, with an average age of 71.
What services does Dr. Jeffrey G. Demain bill to Medicare?
In 2024, Dr. Demain's most billed Medicare services were injected or infused drug (J2356), injected or infused drug (J1439) and injected or infused drug (J1306).
Show 6 more questionsShow fewer questions
Where did Dr. Jeffrey G. Demain go to medical school?
Dr. Demain graduated from Texas Tech University Health Science Center School of Medicine in 1987.
What drugs does Dr. Jeffrey G. Demain prescribe most?
In 2023 Medicare Part D data, Dr. Demain's most prescribed drugs by claims were Ipratropium Bromide, Budesonide-Formoterol Fumarate and Breo Ellipta.
Has Dr. Jeffrey G. Demain received payments from drug or device companies?
CMS Open Payments shows $230,347 in general payments to Dr. Demain from 36 companies from 2016 to 2025. The largest total came from Blueprint Medicines Corporation.
How long has Dr. Jeffrey G. Demain been practicing?
Dr. Demain graduated from medical school in 1987, 39 years ago.
Does Dr. Jeffrey G. Demain do research?
Dmand AI links 19 publications to Dr. Demain, published from 2011 to 2025.
Who does Dr. Jeffrey G. Demain publish with?
Dr. Demain's most frequent co-authors are John R. Cohn, MD (3 shared papers), David Alan Khan, MD (2 shared papers) and Wanda Phipatanakul, MD, MS (2 shared papers).
Selling to allergy and immunology practices?
See allergists and immunologists in Alaska by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card